SCHEMBL6988762

SCHEMBL6988762

Nc1nccnc1Sc1nnc(S)s1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
ICAM1 P05362 1/20 0.31
SELE P16581 1/20 0.31
VCAM1 P19320 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991176 0.79 ICAM1 (0.43) MAPTICAM1SELEVCAM1
SCHEMBL6987163 0.79 MAPT (0.38) MAPTICAM1SELEVCAM1
SCHEMBL6994384 0.76 ALDH1A1 (0.50) MAPTICAM1SELEVCAM1
SCHEMBL6992257 0.73 MAPT (0.42) MAPTICAM1SELEVCAM1
SCHEMBL6989319 0.72 ALDH1A1 (0.35) MAPTICAM1SELEVCAM1
SCHEMBL6989328 0.72 ALDH1A1 (0.43) MAPTICAM1SELEVCAM1
SCHEMBL760613 0.72 FBP1 (0.31)
SCHEMBL14301475 0.68
SCHEMBL21695274 0.64
SCHEMBL918273 0.63 FBP1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2452683-A2 Methods for treating atherosclerosis Amgen Inc. (US) 2012-05-16 EP disclosed
EP-2037928-B1 METHODS FOR TREATING ATHEROSCLEROSIS AMGEN INC (US) 2012-01-11 EP disclosed
WO-2008002591-A2 METHODS FOR TREATING ATHEROSCLEROSIS AMGEN INC (US) 2008-01-03 WO disclosed